Sydney Jennings

Articles

FDA Approves First Monotherapy Standalone MDD Treatment: Daily Dose

January 31, 2025

Your daily dose of the clinical news you may have missed.

Axsome Therapeutics: FDA Approves Symbravo for Acute Treatment of Migraine

January 30, 2025

A single oral dose of Symbravo provided rapid migraine pain freedom and return to normal functioning within 2 hours, and sustained efficacy through 24 and 48 hours.

Investigational RSV Antiviral Treatment Reduces Viral Load in Phase 2 Human Challenge Trial

January 30, 2025

The study of S-337395 showed an 88.9% reduction in RSV viral load and symptom improvement in the highest dose group, with no severe adverse events reported.

Tool Predicts Age at Cognitive Impairment, Dementia Onset: Daily Dose

January 30, 2025

Your daily dose of the clinical news you may have missed.

PTSD Treatment Advancements: Brexpiprazole-Sertraline Offers New Hope in Phase 3 Trial

January 29, 2025

Data showed that brexpiprazole plus sertraline significantly improved PTSD symptoms vs sertraline alone. Lead author, Lori Davis, MD, discusses more.

FDA Grants Breakthrough Device Designation for Alzheimer Disease Blood Test

January 29, 2025

The Access p-Tau217/β-Amyloid 1-42 plasma ratio blood test is designed to help identify patients with amyloid pathology associated with AD.

High-Dose Semaglutide Linked to Increased Weight Loss: Daily Dose

January 29, 2025

Your daily dose of the clinical news you may have missed.

FDA Approves New Indication for Semaglutide (Ozempic) to Lower Kidney Risks in Type 2 Diabetes, CKD

January 28, 2025

This newest approval established Ozempic as the most broadly indicted GLP-1 RA in its class.

Bariatric Surgery Lowers Risk of Liver Complications in Patients with Cirrhosis, Obesity

January 28, 2025

Metabolic surgery reduced major adverse liver outcomes in people with compensated cirrhosis and obesity by 72%, according to new data.

AI Model Identifies Women with Subjective Cognitive Decline During Menopause: Daily Dose

January 28, 2025

Your daily dose of the clinical news you may have missed.